批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2022/07/28 |
SUPPL-8(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2021/03/05 |
SUPPL-7(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2019/09/16 |
SUPPL-6(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2019/09/16 |
SUPPL-5(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2019/09/16 |
SUPPL-3(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2019/09/16 |
SUPPL-2(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/07/14 |
ORIG-1(原始申请) |
Approval |
|
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:PANTOPRAZOLE SODIUM 剂型/给药途径:INJECTABLE;INTRAVENOUS 规格:EQ 40MG BASE/VIAL 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020988 |
001 |
NDA |
PROTONIX IV |
PANTOPRAZOLE SODIUM |
INJECTABLE;INTRAVENOUS |
EQ 40MG BASE/VIAL |
Prescription |
Yes |
Yes |
AP |
2001/03/22
|
WYETH PHARMS |
079197 |
001 |
ANDA |
PANTOPRAZOLE SODIUM |
PANTOPRAZOLE SODIUM |
INJECTABLE;INTRAVENOUS |
EQ 40MG BASE/VIAL |
Prescription |
No |
No |
AP |
2012/11/08
|
EPIC PHARMA LLC |
090296 |
001 |
ANDA |
PANTOPRAZOLE SODIUM |
PANTOPRAZOLE SODIUM |
INJECTABLE;INTRAVENOUS |
EQ 40MG BASE/VIAL |
Prescription |
No |
No |
AP |
2015/07/14
|
SANDOZ |
205675 |
001 |
ANDA |
PANTOPRAZOLE SODIUM |
PANTOPRAZOLE SODIUM |
INJECTABLE;INTRAVENOUS |
EQ 40MG BASE/VIAL |
Prescription |
No |
No |
AP |
2016/03/30
|
EUGIA PHARMA |
077674 |
001 |
ANDA |
PANTOPRAZOLE SODIUM |
PANTOPRAZOLE SODIUM |
INJECTABLE;INTRAVENOUS |
EQ 40MG BASE/VIAL |
Discontinued |
No |
No |
AP |
2019/08/19
|
SUN PHARM |
209524 |
001 |
ANDA |
PANTOPRAZOLE SODIUM |
PANTOPRAZOLE SODIUM |
INJECTABLE;INTRAVENOUS |
EQ 40MG BASE/VIAL |
Prescription |
No |
No |
AP |
2021/08/30
|
HANGZHOU ZHONGMEI |
213778 |
001 |
ANDA |
PANTOPRAZOLE SODIUM |
PANTOPRAZOLE SODIUM |
INJECTABLE;INTRAVENOUS |
EQ 40MG BASE/VIAL |
Prescription |
No |
No |
AP |
2022/05/18
|
ASPIRO |
204400 |
001 |
ANDA |
PANTOPRAZOLE SODIUM |
PANTOPRAZOLE SODIUM |
INJECTABLE;INTRAVENOUS |
EQ 40MG BASE/VIAL |
Prescription |
No |
No |
AP |
2022/05/18
|
GLAND PHARMA LTD |
216171 |
001 |
ANDA |
PANTOPRAZOLE SODIUM |
PANTOPRAZOLE SODIUM |
INJECTABLE;INTRAVENOUS |
EQ 40MG BASE/VIAL |
Prescription |
No |
No |
AP |
2022/05/18
|
BE PHARMS |
214680 |
001 |
ANDA |
PANTOPRAZOLE SODIUM |
PANTOPRAZOLE SODIUM |
INJECTABLE;INTRAVENOUS |
EQ 40MG BASE/VIAL |
Prescription |
No |
No |
AP |
2022/05/19
|
KNACK |
215860 |
001 |
ANDA |
PANTOPRAZOLE SODIUM |
PANTOPRAZOLE SODIUM |
INJECTABLE;INTRAVENOUS |
EQ 40MG BASE/VIAL |
Prescription |
No |
No |
AP |
2022/08/29
|
MEITHEAL |